Page last updated: 2024-08-17

cytidine triphosphate and Triple Negative Breast Neoplasms

cytidine triphosphate has been researched along with Triple Negative Breast Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Chen, L; Chen, M; Chen, X; Fu, F; Guo, W; Jiang, M; Jin, X; Li, Y; Lin, Y; Song, C; Wang, C; Xiao, H; Zhang, J; Zhang, W1

Other Studies

1 other study(ies) available for cytidine triphosphate and Triple Negative Breast Neoplasms

ArticleYear
CTPS1 promotes malignant progression of triple-negative breast cancer with transcriptional activation by YBX1.
    Journal of translational medicine, 2022, 01-06, Volume: 20, Issue:1

    Topics: Animals; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cytidine Triphosphate; Gene Expression Regulation, Neoplastic; Humans; Mice; Nucleotides; Transcriptional Activation; Triple Negative Breast Neoplasms; Y-Box-Binding Protein 1

2022